Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07TRV
|
|||
| Former ID |
DIB007233
|
|||
| Drug Name |
Anthrax vaccine
|
|||
| Synonyms |
Anthrax vaccine, DynPort/AVANT; Injectable anthrax vaccine, DynPort/AVANT; Anthrax vaccine (injectable), DynPort/AVANT
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Bacillus anthracis infection [ICD-11: 1G40] | Discontinued in Phase 1 | [1] | |
| Company |
Celldex Therapeutics Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bacterial Protective antigen (Bact pagA) | Target Info | . | [2] |
| Pathway Interaction Database | Cellular roles of Anthrax toxin | |||
| Reactome | Uptake and function of anthrax toxins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017549) | |||
| REF 2 | Annual Reports in Medicinal Chemistry. Annette M. Doherty. 2005. Page(214). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.